1-5 of 5
Anil Ananthaneni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Are We Diagnosing and Managing Diabetes in Patients with Sickle Cell Disorders Accurately?

Anil Ananthaneni, Nakoma Walker, Rahul Vyas, Francesca Weis, David Heap, Sriram Chowdary, Nishith Alva, Sara Abdelaziz, Poornima Ramadas
Journal: Blood
Blood (2023) 142 (Supplement 1): 2301.
https://doi.org/10.1182/blood-2023-182540
Published: 2023
Journal Articles

Immunosuppressant Drug-Associated Non-Hodgkin Lymphoma: A Real-World Pharmacovigilance Database Analysis

Anil Ananthaneni, David Heap, Francesca Weis, Sriram Chowdary, Riya Sam, Zaki Al-Yafeai, Poornima Ramadas
Journal: Blood
Blood (2023) 142 (Supplement 1): 6268.
https://doi.org/10.1182/blood-2023-182518
Published: 2023
Journal Articles

ADAMTS13 Overtesting in Hospitalized Patients with Suspected TTP: A Retrospective Study

Anil Ananthaneni, Udhayvir Singh Grewal, Tyiesha Sharron Brown, Zaki Al-Yafeai, Samip R. Master, Kavitha Beedupalli
Journal: Blood
Blood (2022) 140 (Supplement 1): 5019–5020.
https://doi.org/10.1182/blood-2022-170700
Published: 2022
Journal Articles

Outcomes in Pregnant HbSS and HbSβ0-Thalassemia Sickle Cell Disease Patients Receiving Scheduled Exchange Transfusions: A Retrospective Study

Anil Ananthaneni, Taras Benzar, Vishwa Grant, Kenna Leethy, Jacqueline Walton, Samip R Master, Richard Preston Mansour, Poornima Ramadas
Journal: Blood
Blood (2022) 140 (Supplement 1): 10867–10868.
https://doi.org/10.1182/blood-2022-170909
Published: 2022
Journal Articles

Comparison of Adverse Event Profiles of Rituximab, Rituximab Hycela and Rituximab Biosimilars: A Real-World Pharmacovigilance Database Analysis

Dinesh Keerty, Anil Ananthaneni, Poornima Ramadas, Samip R Master
Journal: Blood
Blood (2022) 140 (Supplement 1): 13196–13197.
https://doi.org/10.1182/blood-2022-167269
Published: 2022